Login

ESSA Pharma Inc. SEC Filings

Filed On Filing
14 Nov 2025 EFFECT
14 Nov 2025 SCHEDULE 13G/A
14 Nov 2025 SCHEDULE 13G/A
28 Oct 2025 15-12G
15 Oct 2025 Form 4: Parkinson David Ross, Director

Returned 65,675 shares to the issuer

15 Oct 2025 Form 4: Wood David S., Chief Financial Officer

Returned 33,343 shares to the issuer

15 Oct 2025 Form 4: Berger Franklin M, Director

Returned 784,404 shares to the issuer

15 Oct 2025 Form 4: Glickman Richard M, Director

Returned 43,240 shares to the issuer

15 Oct 2025 Form 4: Requadt Scott, Director

Returned 30,002 shares to the issuer

15 Oct 2025 Form 4: Martin John Alexander, Director

Returned 14,299 shares to the issuer

15 Oct 2025 Form 4: Thorell Marella, Director

Returned 2,881 shares to the issuer

15 Oct 2025 POS AM
15 Oct 2025 S-8 POS
15 Oct 2025 S-8 POS
15 Oct 2025 S-8 POS
15 Oct 2025 S-8 POS
15 Oct 2025 S-8 POS
14 Oct 2025 Form 4: Bvf Partners L P/IL, 10% owner and 9 others

Disposed of 11,481,685 shares (Tender Offer)

14 Oct 2025 SCHEDULE 13D/A
09 Oct 2025 25-NSE

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support